Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy

Experimental Hematology

Volumn 35, Issue 3, 2007, Pages 407-415

  Inoue, Yusuke ^a   Izawa, Kiyoko ^b   Tojo, Arinobu ^b   Nomura, Yukihiro ^c   Sekine, Rieko ^b   Oyaizu, Naoki ^a   Ohtomo, Kuni ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; LUCIFERASE; PROTEIN P190;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BONE MARROW; CELL PROLIFERATION; CELL STRAIN; CORRELATION COEFFICIENT; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; GENETIC TRANSDUCTION; HEMATOLOGIC MALIGNANCY; HEPATOSPLENOMEGALY; IMAGING; IN VIVO STUDY; INOCULATION; LIVER NODULE; LIVER WEIGHT; LONGITUDINAL STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEASIBILITY STUDIES; HEMATOLOGIC NEOPLASMS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM TRANSPLANTATION; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ANIMALIA; MUS;

EID: 33847066329     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.11.006     Document Type: Article

References (37)

1. Contag C.H., Jenkins D., Contag P.R., and Negrin R.S. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2 (2000) 41-52
2. Edinger M., Cao Y.A., Hornig Y.S., et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38 (2002) 2128-2136
3. Day J.C., Tisi L.C., and Bailey M.J. Evolution of beetle bioluminescence: the origin of beetle luciferin. Luminescence 19 (2004) 8-20
4. Choy G., O'Connor S., Diehn F.E., et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35 (2003) 1022-1030
5. Paroo Z., Bollinger R.A., Braasch D.A., et al. Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3 (2004) 117-124
6. Nogawa M., Yuasa T., Kimura S., et al. Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. Cancer Lett 217 (2005) 243-253
7. Rehemtulla A., Stegman L.D., Cardozo S.J., et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2 (2000) 491-495
8. Szentirmai O., Baker C.H., Lin N., et al. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 58 (2006) 365-372
9. Nyati M.K., Symon Z., Kievit E., et al. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther 9 (2002) 844-849
10. Smakman N., Martens A., Kranenburg O., and Borel Rinkes I.H. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res 122 (2004) 225-230
11. Mandl S.J., Mari C., Edinger M., et al. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging 3 (2004) 1-8
12. Jenkins D.E., Oei Y., Hornig Y.S., et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20 (2003) 733-744
13. Scatena C.D., Hepner M.A., Oei Y.A., et al. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer. Prostate 59 (2004) 292-303
14. Zeamari S., Rumping G., Floot B., Lyons S., and Stewart F.A. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. Br J Cancer 90 (2004) 1259-1264
15. Edinger M., Cao Y.A., Verneris M.R., Bachmann M.H., Contag C.H., and Negrin R.S. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101 (2003) 640-648
16. Shah N.P., Tran C., Lee F.Y., Chen P., Norris D., and Sawyers C.L. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305 (2004) 399-401
17. Wu K.D., Cho Y.S., Katz J., et al. Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. Proc Natl Acad Sci U S A 102 (2005) 10640-10645
18. Weisberg E., Manley P.W., Breitenstein W., et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 7 (2005) 129-141
19. Yoshimitsu M., Sato T., Tao K., et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci U S A 101 (2004) 16909-16914
20. Carlsen H., Moskaug J.O., Fromm S.H., and Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 168 (2002) 1441-1446
21. Inoue Y., Izawa K., Tojo A., Sekine R., Okubo T., and Ohtomo K. Light emission requires exposure to the atmosphere in ex vivo bioluminescence imaging. Mol Imaging 5 (2006) 53-56
22. Haishi T., Uematsu T., Matsuda Y., and Kose K. Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet. Magn Reson Imaging 19 (2001) 875-880
23. Inoue Y., Nomura Y., Haishi T., et al. Imaging of living mice using a 1-T compact magnetic resonance imaging system. J Magn Reson Imaging 24 (2006) 901-907
24. Garbow J.R., Kataoka M., and Flye M.W. MRI measurement of liver regeneration in mice following partial hepatectomy. Magn Reson Med 52 (2004) 177-180
25. Inderbitzin D., Gass M., Beldi G., et al. Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver. J Gastrointest Surg 8 (2004) 806-811
26. Allegrini P.R., and Wachsmuth E.D. Course of murine leukemia retrovirus infection determined in vivo by magnetic resonance imaging. Lab Invest 63 (1990) 568-575
27. Inoue Y., Tojo A., Sekine R., et al. In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals. Eur J Nucl Med Mol Imaging 33 (2006) 557-565
28. Copelan E.A., and McGuire E.A. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 85 (1995) 1151-1168
29. Li S., Ilaria Jr. R.L., Million R.P., Daley G.Q., and Van Etten R.A. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189 (1999) 1399-1412
30. Reimer P., Schneider G., and Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14 (2004) 559-578
31. Rice B.W., Cable M.D., and Nelson M.B. In vivo imaging of light-emitting probes. J Biomed Opt 6 (2001) 432-440
32. El Hilali N., Rubio N., Martinez-Villacampa M., and Blanco J. Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab Invest 82 (2002) 1563-1571
33. Honigman A., Zeira E., Ohana P., et al. Imaging transgene expression in live animals. Mol Ther 4 (2001) 239-249
34. Burgos J.S., Rosol M., Moats R.A., et al. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. Biotechniques 34 (2003) 1184-1188
35. Kreft B.P., Tanimoto A., Stark D.D., et al. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J Magn Reson Imaging 3 (1993) 41-49
36. Kim Y.K., Lee J.M., and Kim C.S. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14 (2004) 5-13
37. Gauvain K.M., Garbow J.R., Song S.K., Hirbe A.C., and Weilbaecher K. MRI detection of early bone metastases in b16 mouse melanoma models. Clin Exp Metastasis 22 (2005) 403-411